Priit Palta

Priit Palta

Auto-generated profile, based on publicly available information

Priit Palta

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2014 in Nature
Verified
Journal Article
Closed access
PDF file
MFMenachem Fromer
Menachem Fromer
APAndrew J. Pocklington
Andrew J. Pocklington
DKDavid H. Kavanagh
David H. Kavanagh
HWHywel Williams
Hywel Williams
SDSarah Dwyer
Sarah Dwyer
MOMichael C. O’donovan
Michael C. O’donovan

22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
TCThe Brainstorm Consortium
The Brainstorm Consortium
VAVerneri Anttila
Verneri Anttila
BBBrendan Bulik-Sullivan
Brendan Bulik-Sullivan
HFHilary K. Finucane
Hilary K. Finucane
RWRaymond K. Walters
Raymond K. Walters
BNBenjamin M. Neale
Benjamin M. Neale
Brainstorming diseases: Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple genome-wide association studies drawn from more than 200,000 patients for 25 brain-associated disorders and 17 phenotypes. Broadly, it appears that psychiatric and neurologic disorders share relatively little common genetic risk. However, different and independent pathways can result in similar clinical manifestations (e.g., psychosis, which occurs in both schizophrenia and Alzheimer's disease). Schizophrenia correlated with many psychiatric disorders, whereas the immunopathological affliction Crohn's disease did not, and posttraumatic stress syndrome was also largely independent of underlying traits. Essentially, the earlier the onset of a disorder, the more inheritable it appeared to be. Science , this issue p. eaap8757

20 June 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ICInternational Headache Genetics Consortium
International Headache Genetics Consortium
PGPadhraig Gormley
Padhraig Gormley
VAVerneri Anttila
Verneri Anttila
BWBendik S Winsvold
Bendik S Winsvold
PPPriit Palta
Priit Palta
APAarno Palotie
Aarno Palotie

4 February 2010 in Nature
Verified
Journal Article
Open access
PDF file
RWRobin Walters
Robin Walters
SJS. Jacquemont
S. Jacquemont
AVA. Valsesia
A. Valsesia
ASA. J. de Smith
A. J. de Smith
DMD. Martinet
D. Martinet
JBJ. S. Beckmann
J. S. Beckmann
Obesity is a highly heritable disorder but the genetic associations reported to date account for only a small percentage of the inherited variation in body mass index. Two groups report deletions on chromosome16p11.2 that may explain part of the 'missing heritability' in terms of 'high-penetrance' mutations that are rare but when present are very often associated with severe obesity. This is in contrast to more common gene defects that are less closely associated with clinical symptoms. Bochukova et al. identified rare recurrent copy number variants in 300 patients with severe early-onset obesity, caused by deletions involving several genes including SH2B1, known to be involved in leptin and insulin signalling. Many of the patients also suffered neurodevelopmental disorders. Walters et al. identified deletions of at least 593 kilobases on chromosome 16p11.2 in 31 patients with a previously unrecognized type of extreme obesity. The strategy they used to identify the lesion — using small well-phenotyped cohorts of extreme phenotypes with targeted follow-up in genome-wide association studies and population cohorts — shows promise as a means of identifying 'missing heritability' in complex metabolic diseases more generally. Recently, numerous single nucleotide polymorphisms have been identified as being associated with obesity, but these loci together account for only a small fraction of the known heritable component. Here, an association is reported between rare deletions of at least 593 kilobases at 16p11.2 and a highly penetrant form of obesity. The strategy used of combining study of extreme phenotypes with targeted follow-up is promising for identifying missing heritability in obesity. Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western ‘obesogenic’ environment and a strong genetic contribution1. Recent extensive genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms associated with obesity, but these loci together account for only a small fraction of the known heritable component1. Thus, the ‘common disease, common variant’ hypothesis is increasingly coming under challenge2. Here we report a highly penetrant form of obesity, initially observed in 31 subjects who were heterozygous for deletions of at least 593 kilobases at 16p11.2 and whose ascertainment included cognitive deficits. Nineteen similar deletions were identified from GWAS data in 16,053 individuals from eight European cohorts. These deletions were absent from healthy non-obese controls and accounted for 0.7% of our morbid obesity cases (body mass index (BMI) ≥ 40 kg m-2 or BMI standard deviation score ≥ 4; P = 6.4 × 10-8, odds ratio 43.0), demonstrating the potential importance in common disease of rare variants with strong effects. This highlights a promising strategy for identifying missing heritability in obesity and other complex traits: cohorts with extreme phenotypes are likely to be enriched for rare variants, thereby improving power for their discovery. Subsequent analysis of the loci so identified may well reveal additional rare variants that further contribute to the missing heritability, as recently reported for SIM1 (ref. 3). The most productive approach may therefore be to combine the ‘power of the extreme’4 in small, well-phenotyped cohorts, with targeted follow-up in case-control and population cohorts.

7 April 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
FGFinn Gen
Finn Gen
NMNina Mars
Nina Mars
JKJukka T. Koskela
Jukka T. Koskela
PRPietari Ripatti
Pietari Ripatti
TKTuomo T. J. Kiiskinen
Tuomo T. J. Kiiskinen
SRSamuli Ripatti
Samuli Ripatti

23 June 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NCNorth American Brain Expression Consortium
North American Brain Expression Consortium
VAVerneri Anttila
Verneri Anttila
UCUK Brain Expression Consortium
UK Brain Expression Consortium
TCthe International Headache Genetics Consortium
the International Headache Genetics Consortium
BWBendik S Winsvold
Bendik S Winsvold
MDMark J Daly
Mark J Daly
Verneri Anttila and colleagues report meta-analysis of 29 genome-wide association studies for migraine. They identify five loci newly associated with migraine, three of which are associated with specific subtypes of migraine with or without aura. Migraine is the most common brain disorder, affecting approximately 14% of the adult population, but its molecular mechanisms are poorly understood. We report the results of a meta-analysis across 29 genome-wide association studies, including a total of 23,285 individuals with migraine (cases) and 95,425 population-matched controls. We identified 12 loci associated with migraine susceptibility (P < 5 × 10−8). Five loci are new: near AJAP1 at 1p36, near TSPAN2 at 1p13, within FHL5 at 6q16, within C7orf10 at 7p14 and near MMP16 at 8q21. Three of these loci were identified in disease subgroup analyses. Brain tissue expression quantitative trait locus analysis suggests potential functional candidate genes at four loci: APOA1BP, TBC1D7, FUT9, STAT6 and ATP5B.